Detalhe da pesquisa
1.
Synergistic effects of agonists and two-pore-domain potassium channels on secretory responses of human pancreatic duct cells Capan-1.
Pflugers Arch
; 475(3): 361-379, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36534232
2.
Topology impacts TRAIL therapy: Differences in primary cancer growth and liver metastasis between orthotopic and subcutaneous xenotransplants of pancreatic ductal adenocarcinoma cells.
Hepatobiliary Pancreat Dis Int
; 20(3): 279-284, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33947634
3.
The A818-6 system as an in-vitro model for studying the role of the transportome in pancreatic cancer.
BMC Cancer
; 20(1): 264, 2020 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32228510
4.
Dasatinib prevents skeletal metastasis of osteotropic MDA-MB-231 cells in a xenograft mouse model.
Arch Gynecol Obstet
; 301(6): 1493-1502, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32170411
5.
Cytoplasmic TRAIL-R1 is a positive prognostic marker in PDAC.
BMC Cancer
; 18(1): 777, 2018 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-30064384
6.
Nuclear death receptor TRAIL-R2 inhibits maturation of let-7 and promotes proliferation of pancreatic and other tumor cells.
Gastroenterology
; 146(1): 278-90, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24120475
7.
TRAIL-induced programmed necrosis as a novel approach to eliminate tumor cells.
BMC Cancer
; 14: 74, 2014 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-24507727
8.
TRAIL-induced expression of uPA and IL-8 strongly enhanced by overexpression of TRAF2 and Bcl-xL in pancreatic ductal adenocarcinoma cells.
Hepatobiliary Pancreat Dis Int
; 12(1): 94-8, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23392805
9.
Soluble and transmembrane TNF-like weak inducer of apoptosis differentially activate the classical and noncanonical NF-kappa B pathway.
J Immunol
; 185(3): 1593-605, 2010 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20610643
10.
Impact of Extracellular pH on Apoptotic and Non-Apoptotic TRAIL-Induced Signaling in Pancreatic Ductal Adenocarcinoma Cells.
Front Cell Dev Biol
; 10: 768579, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35281089
11.
Endogenous TRAIL-R4 critically impacts apoptotic and non-apoptotic TRAIL-induced signaling in cancer cells.
Front Cell Dev Biol
; 10: 942718, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36158196
12.
Epicatechin gallate and catechin gallate are superior to epigallocatechin gallate in growth suppression and anti-inflammatory activities in pancreatic tumor cells.
Cancer Sci
; 102(4): 728-34, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21241417
13.
Assessment of anti-inflammatory tumor treatment efficacy by longitudinal monitoring employing sonographic micro morphology in a preclinical mouse model.
BMC Med Imaging
; 11: 15, 2011 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-21699694
14.
Engineering of CD19 Antibodies: A CD19-TRAIL Fusion Construct Specifically Induces Apoptosis in B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Cells In Vivo.
J Clin Med
; 10(12)2021 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34203833
15.
TRAIL-receptor 2-a novel negative regulator of p53.
Cell Death Dis
; 12(8): 757, 2021 07 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34333527
16.
Prognostic significance of high mobility group A2 (HMGA2) in pancreatic ductal adenocarcinoma: malignant functions of cytoplasmic HMGA2 expression.
J Cancer Res Clin Oncol
; 147(11): 3313-3324, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34302528
17.
Cytoplasmic levels of high mobility group A2 determine survival prognoses in breast cancer patients.
Int J Biol Markers
; 35(2): 20-28, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32394766
18.
Impact of p53 status on TRAIL-mediated apoptotic and non-apoptotic signaling in cancer cells.
PLoS One
; 14(4): e0214847, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30947287
19.
The expression of death receptor systems TRAIL-R1/-R2/-R4, CD95 and TNF-R1 and their cognate ligands in pancreatic ductal adenocarcinoma.
Histol Histopathol
; 34(5): 491-501, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30375637
20.
TRAILblazing Strategies for Cancer Treatment.
Cancers (Basel)
; 11(4)2019 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30935038